Trade Arcutis Biotherapeutics, Inc. - ARQT CFD
What is Arcutis Biotherapeutics, Inc. (ARQT)?
Arcutis Biotherapeutics, Inc. is a biopharmaceutical company focused on developing treatments for dermatological conditions. Its research and development efforts concentrate on therapies for inflammatory skin diseases, including psoriasis, atopic dermatitis, and other chronic skin disorders. The company employs a pipeline of topical and systemic drug candidates designed to address the underlying causes of these conditions. Arcutis Biotherapeutics utilizes proprietary formulations and delivery technologies to improve treatment efficacy and patient adherence. It operates within the specialty pharmaceutical sector, aiming to provide novel therapeutic options for dermatology patients. The company engages in clinical development and regulatory activities to advance its product candidates. Its mission includes addressing significant unmet needs in dermatology through innovative treatment approaches.
Arcutis Biotherapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by Arcutis Biotherapeutics, Inc. as it trades at $23.65. Intraday price swings have hit $21.39 and $23.47, with a daily percentage change of +9.4544%.
FAQ: Arcutis Biotherapeutics, Inc. (ARQT)
What is the current price of ARQT stock?
The current stock price stands at $23.65.
Does ARQT pay dividends?
Arcutis Biotherapeutics, Inc. does not pay dividends.
Does ARQT have a formal corporate presence or regional headquarters in the UAE?
Arcutis Biotherapeutics, Inc. does not have an official presence in the UAE and operates via partners or distributors.
What is ARQT best known for?
The company is most famous for its dermatology-focused biopharmaceutical products.
What assets are typically shown together with ARQT?
Commonly shown alongside ARQT: UBS Group AG - CH, Expeditors, Spotify Technology SA
Latest shares articles



